Skip to main content
. 2018 Jun 29;9(50):29445–29452. doi: 10.18632/oncotarget.25655

Figure 3.

Figure 3

DFS curves (in months) for MACROD2 expression in MSS colon cancer patients who did not receive (A, C) and did receive (B, D) 5-FU-based adjuvant chemotherapy for stage II (A, B) and stage III (C, D) colon cancer patients. Log-rank p-values and Cox regression HRs (95% CI) are reported.